Cargando…
Characteristics of aldosterone-producing adenomas in patients without plasma renin activity suppression
Primary aldosteronism (PA) usually accompanies suppressed plasma renin activity (PRA) through a negative feedback mechanism. While some cases of PA with unsuppressed PRA were reported, there have been no studies about the characteristics of PA with unsuppressed PRA; thus, these characteristics were...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9049528/ https://www.ncbi.nlm.nih.gov/pubmed/35482752 http://dx.doi.org/10.1371/journal.pone.0267732 |
_version_ | 1784696157811769344 |
---|---|
author | Kubo, Haremaru Tsurutani, Yuya Inoue, Kosuke Watanabe, Kazuki Yamazaki, Yuto Sunouchi, Takashi Hoshino, Yoshitomo Hirose, Rei Katsuragawa, Sho Tannai, Hiromitsu Shibahara, Yukiko Kakuta, Yukio Matsui, Seishi Saito, Jun Omura, Masao Sasano, Hironobu Nishikawa, Tetsuo |
author_facet | Kubo, Haremaru Tsurutani, Yuya Inoue, Kosuke Watanabe, Kazuki Yamazaki, Yuto Sunouchi, Takashi Hoshino, Yoshitomo Hirose, Rei Katsuragawa, Sho Tannai, Hiromitsu Shibahara, Yukiko Kakuta, Yukio Matsui, Seishi Saito, Jun Omura, Masao Sasano, Hironobu Nishikawa, Tetsuo |
author_sort | Kubo, Haremaru |
collection | PubMed |
description | Primary aldosteronism (PA) usually accompanies suppressed plasma renin activity (PRA) through a negative feedback mechanism. While some cases of PA with unsuppressed PRA were reported, there have been no studies about the characteristics of PA with unsuppressed PRA; thus, these characteristics were examined herein. Nine patients with unsuppressed PRA and 86 patients with suppressed PRA were examined. All patients underwent segmental adrenal venous sampling (sAVS) and adrenalectomy, and were pathologically confirmed to have cytochrome P450 11B2 (CYP11B2)-positive aldosterone-producing adenoma according to international histopathology consensus criteria. Unsuppressed and suppressed PRA were defined as PRA levels of > 1.0 and ≤ 1.0 ng/mL/hr, respectively, in multiple blood samples obtained in the resting position. The unsuppressed PRA group had higher morning cortisol levels (12.6 [8.5, 13.5] vs. 8.5 [7.1, 11.0] μg/dL, P = 0.03) and higher cortisol levels after a 1 mg dexamethasone suppression test (DST) (2.2 [1.6, 2.5] vs. 1.3 [1.0, 1.9] μ g/dL, P = 0.004) than the suppressed PRA group. The unsuppressed PRA group also showed higher aldosterone levels on the non-surgical side during sAVS (P = 0.02 before adrenocorticotropic hormone (ACTH) stimulation, P = 0.002 after ACTH stimulation), a higher intensity of CYP17 expression in the resected adrenal gland (P = 0.02), and a lower clinical complete success rate 1 year after surgery (P = 0.04) compared with those in the suppressed PRA group. These findings suggest that PA should not be ruled out by unsuppressed PRA among patients with hypertension, particularly when their cortisol levels remain unsuppressed in the 1 mg DST. Meanwhile, it should be acknowledged that patients with unsuppressed PRA have higher aldosterone levels on the non-surgical side, and a lower likelihood of postoperative complete clinical success is to be expected. |
format | Online Article Text |
id | pubmed-9049528 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-90495282022-04-29 Characteristics of aldosterone-producing adenomas in patients without plasma renin activity suppression Kubo, Haremaru Tsurutani, Yuya Inoue, Kosuke Watanabe, Kazuki Yamazaki, Yuto Sunouchi, Takashi Hoshino, Yoshitomo Hirose, Rei Katsuragawa, Sho Tannai, Hiromitsu Shibahara, Yukiko Kakuta, Yukio Matsui, Seishi Saito, Jun Omura, Masao Sasano, Hironobu Nishikawa, Tetsuo PLoS One Research Article Primary aldosteronism (PA) usually accompanies suppressed plasma renin activity (PRA) through a negative feedback mechanism. While some cases of PA with unsuppressed PRA were reported, there have been no studies about the characteristics of PA with unsuppressed PRA; thus, these characteristics were examined herein. Nine patients with unsuppressed PRA and 86 patients with suppressed PRA were examined. All patients underwent segmental adrenal venous sampling (sAVS) and adrenalectomy, and were pathologically confirmed to have cytochrome P450 11B2 (CYP11B2)-positive aldosterone-producing adenoma according to international histopathology consensus criteria. Unsuppressed and suppressed PRA were defined as PRA levels of > 1.0 and ≤ 1.0 ng/mL/hr, respectively, in multiple blood samples obtained in the resting position. The unsuppressed PRA group had higher morning cortisol levels (12.6 [8.5, 13.5] vs. 8.5 [7.1, 11.0] μg/dL, P = 0.03) and higher cortisol levels after a 1 mg dexamethasone suppression test (DST) (2.2 [1.6, 2.5] vs. 1.3 [1.0, 1.9] μ g/dL, P = 0.004) than the suppressed PRA group. The unsuppressed PRA group also showed higher aldosterone levels on the non-surgical side during sAVS (P = 0.02 before adrenocorticotropic hormone (ACTH) stimulation, P = 0.002 after ACTH stimulation), a higher intensity of CYP17 expression in the resected adrenal gland (P = 0.02), and a lower clinical complete success rate 1 year after surgery (P = 0.04) compared with those in the suppressed PRA group. These findings suggest that PA should not be ruled out by unsuppressed PRA among patients with hypertension, particularly when their cortisol levels remain unsuppressed in the 1 mg DST. Meanwhile, it should be acknowledged that patients with unsuppressed PRA have higher aldosterone levels on the non-surgical side, and a lower likelihood of postoperative complete clinical success is to be expected. Public Library of Science 2022-04-28 /pmc/articles/PMC9049528/ /pubmed/35482752 http://dx.doi.org/10.1371/journal.pone.0267732 Text en © 2022 Kubo et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Kubo, Haremaru Tsurutani, Yuya Inoue, Kosuke Watanabe, Kazuki Yamazaki, Yuto Sunouchi, Takashi Hoshino, Yoshitomo Hirose, Rei Katsuragawa, Sho Tannai, Hiromitsu Shibahara, Yukiko Kakuta, Yukio Matsui, Seishi Saito, Jun Omura, Masao Sasano, Hironobu Nishikawa, Tetsuo Characteristics of aldosterone-producing adenomas in patients without plasma renin activity suppression |
title | Characteristics of aldosterone-producing adenomas in patients without plasma renin activity suppression |
title_full | Characteristics of aldosterone-producing adenomas in patients without plasma renin activity suppression |
title_fullStr | Characteristics of aldosterone-producing adenomas in patients without plasma renin activity suppression |
title_full_unstemmed | Characteristics of aldosterone-producing adenomas in patients without plasma renin activity suppression |
title_short | Characteristics of aldosterone-producing adenomas in patients without plasma renin activity suppression |
title_sort | characteristics of aldosterone-producing adenomas in patients without plasma renin activity suppression |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9049528/ https://www.ncbi.nlm.nih.gov/pubmed/35482752 http://dx.doi.org/10.1371/journal.pone.0267732 |
work_keys_str_mv | AT kuboharemaru characteristicsofaldosteroneproducingadenomasinpatientswithoutplasmareninactivitysuppression AT tsurutaniyuya characteristicsofaldosteroneproducingadenomasinpatientswithoutplasmareninactivitysuppression AT inouekosuke characteristicsofaldosteroneproducingadenomasinpatientswithoutplasmareninactivitysuppression AT watanabekazuki characteristicsofaldosteroneproducingadenomasinpatientswithoutplasmareninactivitysuppression AT yamazakiyuto characteristicsofaldosteroneproducingadenomasinpatientswithoutplasmareninactivitysuppression AT sunouchitakashi characteristicsofaldosteroneproducingadenomasinpatientswithoutplasmareninactivitysuppression AT hoshinoyoshitomo characteristicsofaldosteroneproducingadenomasinpatientswithoutplasmareninactivitysuppression AT hiroserei characteristicsofaldosteroneproducingadenomasinpatientswithoutplasmareninactivitysuppression AT katsuragawasho characteristicsofaldosteroneproducingadenomasinpatientswithoutplasmareninactivitysuppression AT tannaihiromitsu characteristicsofaldosteroneproducingadenomasinpatientswithoutplasmareninactivitysuppression AT shibaharayukiko characteristicsofaldosteroneproducingadenomasinpatientswithoutplasmareninactivitysuppression AT kakutayukio characteristicsofaldosteroneproducingadenomasinpatientswithoutplasmareninactivitysuppression AT matsuiseishi characteristicsofaldosteroneproducingadenomasinpatientswithoutplasmareninactivitysuppression AT saitojun characteristicsofaldosteroneproducingadenomasinpatientswithoutplasmareninactivitysuppression AT omuramasao characteristicsofaldosteroneproducingadenomasinpatientswithoutplasmareninactivitysuppression AT sasanohironobu characteristicsofaldosteroneproducingadenomasinpatientswithoutplasmareninactivitysuppression AT nishikawatetsuo characteristicsofaldosteroneproducingadenomasinpatientswithoutplasmareninactivitysuppression |